Pneumotox Online
v2.2
  • RSS Feed
  • Contact
  • News
  • Diagnosing DIRD
  • Browse
  • Available on AppStore Available on AppStore

The Drug-Induced Respiratory Disease Website

Philippe Camus, M.D.

Dijon, France

  • Home
  • Browse by »
  • Drugs
  • Patterns

Rituximab

5

X.n Tumor lysis syndrome (TLS)

1
Last update : 12/08/2013
 
Search
Advanced search
Identify causative drugs
Diagnosing DIRD
1
Drug and radiation history
2
Drug singularity - Correct identification of the drug
3
Consistent timing of exposure v. onset of symptoms
4
Clinical, imaging, BAL, pathological pattern consistent with the specific drug
5
Careful exlusion of another cause
6
Remission of symptoms with removal of drug
7
Recurrence with rechallenge (rarely advisable)
8
Causality assessment
More detailed checklist
See also under
Anti-CD20 antibody therapy
4

Publications

Rituximab and cytokine release syndrome.
Case reports in oncology 2012 Jan;5;134-41 2012 Jan
Diagnosis and treatment of rituximab-induced acute tumor lysis syndrome in patients with diffuse large B-cell lymphoma.
The American journal of the medical sciences 2012 Apr;343;337-41 2012 Apr
Tumor lysis syndrome occurring after the administration of rituximab for posttransplant lymphoproliferative disorder.
Transplantation proceedings 2009 Jun;41;1946-8 2009 Jun
Acute tumor lysis syndrome induced by rituximab in diffuse large B-cell lymphoma.
International journal of hematology 2005 Nov;82;312-4 2005 Nov

Powered by

  • ^
  • Contact
  • Cookies
  • About